Literature DB >> 17062636

Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice.

N Suraweera1, J Haines, A McCart, P Rogers, A Latchford, M Coster, G Polanco-Echeverry, T Guenther, J Wang, O Sieber, I Tomlinson, A Silver.   

Abstract

Min mice provide a good model of human familial adenomatous polyposis. Recently, we have reported on two recombinant inbred lines (I and V) and the location of a modifier (Mom3) close to Apc, which altered polyp numbers in our mice possibly by modifying the frequency of wild-type (WT) allele loss at Apc; mice with severe disease (line V) showed elevated rates of loss. We now show that in line I only, a single pregnancy caused a significant increase in adenoma multiplicity compared with virgin controls (P<0.001) and that an additional pregnancy conferred a similar risk. Pregnancy was linked to both adenoma initiation and enhanced tumour growth in line I mice, and interline crosses indicated that susceptibility to pregnancy-associated adenomas was under genetic control. We found no evidence for the involvement of oestrodial metabolizing genes or the oestrogen receptors (Esr1 and 2) in tumour multiplicity. Importantly, a significantly elevated frequency of WT allele loss at Apc was observed in adenomas from parous mice (line and backcrossed) carrying the line I Min allele relative to equivalent virgin controls (P=0.015). Our results provide the first experimental evidence for genetic determinants controlling pregnancy-associated tumourigenesis; analogous genetic factors may exist in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062636     DOI: 10.1093/hmg/ddl419

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.

Authors:  Stephanie C Nnadi; Rayneisha Watson; Julie Innocent; Gregory E Gonye; Arthur M Buchberg; Linda D Siracusa
Journal:  Carcinogenesis       Date:  2012-05-24       Impact factor: 4.944

2.  Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18.

Authors:  Lawrence N Kwong; Alexandra Shedlovsky; Bryan S Biehl; Linda Clipson; Cheri A Pasch; William F Dove
Journal:  Genetics       Date:  2007-04-15       Impact factor: 4.562

3.  Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.

Authors:  Richard C Crist; Jacquelyn J Roth; Michael P Lisanti; Linda D Siracusa; Arthur M Buchberg
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

Review 4.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

5.  Pregnancy does not influence colonic polyp multiplicity but may modulate upper gastrointestinal disease in patients with FAP.

Authors:  Nirosha Suraweera; Andrew Latchford; Amy McCart; Pauline Rogers; Sarah Spain; Oliver Sieber; Robin Phillips; Ian Tomlinson; Andrew Silver
Journal:  J Med Genet       Date:  2007-05-11       Impact factor: 6.318

Review 6.  More than two decades of Apc modeling in rodents.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Biochim Biophys Acta       Date:  2013-01-17

Review 7.  What are the best routes to effectively model human colorectal cancer?

Authors:  Madeleine Young; Liliana Ordonez; Alan R Clarke
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

8.  Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc (Min/+) mutation.

Authors:  Alexandra Dorman; Daria Baer; Ian Tomlinson; Richard Mott; Fuad A Iraqi
Journal:  BMC Genet       Date:  2016-02-19       Impact factor: 2.797

Review 9.  Efficient protocols and methods for high-throughput utilization of the Collaborative Cross mouse model for dissecting the genetic basis of complex traits.

Authors:  Hanifa J Abu-Toamih Atamni; Fuad A Iraqi
Journal:  Animal Model Exp Med       Date:  2019-07-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.